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Curcumin, the constituent of Curcuma longa, is considered a very promising anticancer agent due to its potent and pleiotropic
antineoplastic activity and low nonspecific toxicity to normal cells. A major hurdle towards clinical realization of curcumin
potential has been limited due to its poor aqueous solubility (11ng/ml) and very low systemic bioavailability. A possible aproach 
to overcome these limitations is the design of nanosized drug delivery systems. In this study we report the preparation, 
characterization and evaluation of drug release profiles of  curcumin loaded Chitosan – Alginate –pegilated calix[4]arenes 
nanoparticles (CS-ALG-PEGCX NPs).
EXPERIMENTAL
Preparation of curcumin loaded Chitosan – Alginate –
pegilated calix[4]arenes nanoparticles (CS-ALG-PEGCX NPs)
Nanoparticles were prepared by ionotropic - pregelation of 
an alginate core, followed by chitosan polyelectrolyte 
complexation.  In order to increase the entrapment  efficiency of 
curcumin into the CH-ALG nanopartcles and to avoid the use of 
organic solvent we first disolve the drug  in an aqueous solution of  
polyoxiethylated tert-butyl calix[4]aren which proved to drastically 
increase the aqueous solubility of curcumin by formation of the 
inclusion complexes.
Quantitative analysis of curcumin encapsulation
For quantitative determination of loaded curcumin a validated UV-
VIS spectroscopic method was used . The absorbance of curcumin
was measured at =427 nm.
Dynamic light scattering
The size and size distribution patterns of curcumin loaded chitosan 
– alginate –pegilated calix[4]arenes nanoparticles were investigated 
by ZetaSizer NanoZS (Malvern Instruments)The parameters were 
evaluated from measurements at scattering angle of 173°, at 25°C.
In vitro drug release studies
The in vitro drug release profiles were studied under simulated 
physiological conditions (pH  7,  37C) for different incubation 
periods of 2, 4, 6, 8, 10, 24, 48 and 96 hours.
RESULTS
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Figure 2. In vitro curcumin release
profile of CH – ALG NPs and CH-
ALG – PEGCX NPs
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Figure 1 Size distribution of curcumin loaded CH-AlG and CH-ALG-
PEGCX nanoparticles
In vitro drug release profiles of both tested formulation showed prolonged 
curcumin release. Chitosan – Alginate – pegilated calix[4] arene nanoparticles 
showed higher drug release - 66% of the loaded curcumin was released at 96 
hour of incubation compared with less than 52 % released drug from  CS– Alg
nanoparticles without  PEG-CX. (Figure 2). This could be attibuted to the 
hydrophilicity of the PEG-CX –curcumin inclusion complexes .
Formulation Size (nm) PDI Zeta-potential
(mV)
Encapsulation 
efficacy (%)
CS – ALG NPs 213.1  4, 3 0,2 - 43,1 35%
CS – ALG –
PEGCX NPs
268  5.6 0,3 - 37, 4 75%
Representative examples of nanoparticles size distribution 
measured at 25 are shown in Fig. 1. The distributions are
monomodal with PDI below 0,3. The apparent hydrodynamic 
diameters of the tested formulation range between 200 and 270 nm.
The encapsulation efficiency of curcumin in calixarene containing NPs 
was over 70% and was found to be  two times higher conpared with 
particles without PEGCX (see Table 1).
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On the ground of the exellent phisico-chemical and
technological properties of the tested nanoparticles we could
consider CS-ALG-PEGCX NPs as promissing drug delivery
platform for curcumin.
